Today, in terms of earnings releases for Canadian stocks, Enerplus Corp. , Husky Energy Inc. , Magna International Inc. , Onex Corp. and Royal Bank of Canada are all scheduled to release their quarterly results. Canadian January inflation figures will also be released.
Onex Corporation today announced its consolidated financial results for the fourth quarter and full year ended December 31, 2016 and an update on matters following year-end. In 2016, Onex and its partners invested or committed to invest close to $2.9 billion in five businesses and one add-on investment, of which Onex' share was approximately $900 million.
Shares of OncoCyte Corp have received an average recommendation of "Buy" from the six analysts that are currently covering the firm. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have given a buy recommendation to the company.
University professor George Karaphillis is increasing his portfolio's diversification in order to lower risk and deal with volatility during the Trump era. University professor George Karaphillis is increasing his portfolio's diversification in order to lower risk and deal with volatility during the Trump era.
's stock had its "buy" rating reissued by equities researchers at Canaccord Genuity in a research report issued to clients and investors on Monday, StockTargetPrices.com reports. Shares of OncoCyte Corp traded up 1.72% during midday trading on Monday, hitting $5.90.